Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


30.01.2017

6 Anticancer Res
3 BJU Int
2 BMC Cancer
1 Br J Radiol
1 Cancer Lett
2 Cancer Res
1 Clin Cancer Res
1 Clin Imaging
6 Eur Urol
1 Int J Cancer
3 Int J Radiat Oncol Biol Phys
2 J Natl Cancer Inst
1 J Urol
1 N Engl J Med
3 Nat Rev Urol
1 PLoS One
1 Prog Urol
1 Prostate


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Res

  1. KARIHTALA P, Rissanen T, Tuominen H
    Male Malignant Phyllodes Breast Tumor After Prophylactic Breast Radiotherapy and Bicalutamide Treatment: A Case Report.
    Anticancer Res. 2016;36:3433-6.
    PubMed     Text format     Abstract available

  2. PORPIGLIA F, DE Luca S, Passera R, Manfredi M, et al
    Multiparametric-Magnetic Resonance/Ultrasound Fusion Targeted Prostate Biopsy Improves Agreement Between Biopsy and Radical Prostatectomy Gleason Score.
    Anticancer Res. 2016;36:4833-9.
    PubMed     Text format     Abstract available

  3. KADONO Y, Nohara T, Kadomoto S, Nakashima K, et al
    Investigating Urinary Conditions Prior to Robot-assisted Radical Prostatectomy in Search of a Desirable Method for Evaluating Post-prostatectomy Incontinence.
    Anticancer Res. 2016;36:4293-8.
    PubMed     Text format     Abstract available

  4. ZUGOR V, Poth S, Kuhn R, Bernat MM, et al
    Is an Extended Prostate Biopsy Scheme Associated with an Improvement in the Accuracy Between the Biopsy Gleason Score and Radical Prostatectomy Pathology? A Multivariate Analysis.
    Anticancer Res. 2016;36:4285-8.
    PubMed     Text format     Abstract available

  5. DI PIERRO GB, Grande P, Mordasini L, Danuser H, et al
    Safety and Efficacy of Robot-assisted Radical Prostatectomy in a Low-volume Center: A 6-year Single-surgeon Experience.
    Anticancer Res. 2016;36:4201-7.
    PubMed     Text format     Abstract available

  6. SAKAUE M, Maeda K, Ohno S, Ito T, et al
    Screening for Identification of Personalized Food to Promote Adiponectin Secretion in Patients with Cancer.
    Anticancer Res. 2016;36:3673-7.
    PubMed     Text format     Abstract available


    BJU Int

  7. SHIN T, Smyth TB, Ukimura O, Ahmadi N, et al
    Detection of Prostate Cancer Using Magnetic Resonance Imaging/Ultrasonography Fusion Targeted Biopsy in African-American Men.
    BJU Int. 2017 Jan 23. doi: 10.1111/bju.13786.
    PubMed     Text format     Abstract available

  8. PELLEGRINI KL, Sanda MG, Patil D, Long Q, et al
    Evaluation of a 24-Gene Signature for Prognosis of Metastatic Events and Prostate Cancer-Specific Mortality.
    BJU Int. 2017 Jan 20. doi: 10.1111/bju.13779.
    PubMed     Text format     Abstract available

  9. FAN L, Wang Y, Chenfei C, Pan J, et al
    Chromogranin A and neurone-specific enolase variations during the first three months of abiraterone therapy predict outcomes in patients with metastatic castration-resistant prostate cancer.
    BJU Int. 2017 Jan 20. doi: 10.1111/bju.13781.
    PubMed     Text format     Abstract available


    BMC Cancer

  10. DEMARK-WAHNEFRIED W, Nix JW, Hunter GR, Rais-Bahrami S, et al
    Erratum to: Feasibility outcomes of a presurgical randomized controlled trial exploring the impact of caloric restriction and increased physical activity versus a wait-list control on tumor characteristics and circulating biomarkers in men electing pr
    BMC Cancer. 2017;17:71.
    PubMed     Text format    

  11. BATAI K, Murphy AB, Ruden M, Newsome J, et al
    Race and BMI modify associations of calcium and vitamin D intake with prostate cancer.
    BMC Cancer. 2017;17:64.
    PubMed     Text format     Abstract available


    Br J Radiol

  12. LIN WC, Muglia VF, Silva GE, Chodraui Filho S, et al
    Multiparametric Magnetic Resonance Imaging of the Prostate: Diagnostic Performance and Inter-reader Agreement of Two Scoring Systems.
    Br J Radiol. 2016 Mar 23:20151056.
    PubMed     Text format     Abstract available


    Cancer Lett

  13. LIN LC, Gao AC, Lai CH, Hsieh JT, et al
    Induction of neuroendocrine differentiation in castration resistant prostate cancer cells by adipocyte differentiation-related protein (ADRP) delivered by exosomes.
    Cancer Lett. 2017 Jan 18. pii: S0304-3835(17)30041.
    PubMed     Text format     Abstract available


    Cancer Res

  14. VAN OORSCHOT B, Uitterhoeve L, Oomen I, Ten Cate R, et al
    Prostate cancer patients with late radiation toxicity exhibit reduced expression of genes involved in DNA double strand break repair and homologous recombination.
    Cancer Res. 2017 Jan 20. pii: canres.1966.2016.
    PubMed     Text format     Abstract available

  15. NANDANA S, Tripathi M, Duan P, Chu CY, et al
    Bone metastasis of prostate cancer can be therapeutically targeted at the TBX2-WNT signaling axis.
    Cancer Res. 2017 Jan 20. pii: canres.0497.2016.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  16. KIM K, Zhang H, LaRosa S, Jebiwott S, et al
    Bombesin Antagonist Based Radiotherapy of Prostate Cancer Combined with WST-11 Vascular Targeted Photodynamic Therapy.
    Clin Cancer Res. 2017 Jan 20. pii: clincanres.2745.2016.
    PubMed     Text format     Abstract available


    Clin Imaging

  17. WETTER A, Gruneisen J, Fliessbach K, Lutje S, et al
    Choline-based imaging of prostate cancer with combined [18F] fluorocholine PET and 1H MR spectroscopy by means of integrated PET/MRI.
    Clin Imaging. 2017;42:198-202.
    PubMed     Text format     Abstract available


    Eur Urol

  18. ZILLI T, Crehange G, Chapet O
    Re: Pascal Rischmann, Albert Gelet, Benjamin Riche, et al. Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111 Patients. Eur Urol. In press. http://dx.doi.org/10.1016/j.
    Eur Urol. 2017 Jan 16. pii: S0302-2838(17)30016.
    PubMed     Text format    

  19. KALLIDONIS P, Liatsikos E
    Re: Long-term Results of Active Surveillance in the Goteborg Randomized, Population-based Prostate Cancer Screening Trial.
    Eur Urol. 2017 Jan 16. pii: S0302-2838(17)30014.
    PubMed     Text format    

  20. FOSSATI N, Willemse PM, van den Bergh RC, Van den Broeck T, et al
    The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review.
    Eur Urol. 2017 Jan 23. pii: S0302-2838(16)30900.
    PubMed     Text format     Abstract available

  21. EPSTEIN JI, Trock B, Han M
    Reply to Christian Daniel Fankhauser, Lorelei A. Mucci, and Travis A. Gerke's Letter to the Editor re: Won Sik Ham, Heather J. Chalfin, Zhaoyong Feng, et al. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason
    Eur Urol. 2017 Jan 17. pii: S0302-2838(17)30011.
    PubMed     Text format    

  22. FANKHAUSER CD, Mucci LA, Gerke TA
    Re: Won Sik Ham, Heather J. Chalfin, Zhaoyong Feng, et al. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.11.006.
    Eur Urol. 2017 Jan 17. pii: S0302-2838(17)30032.
    PubMed     Text format    

  23. DE LAERE B, van Dam PJ, Whitington T, Mayrhofer M, et al
    Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns.
    Eur Urol. 2017 Jan 16. pii: S0302-2838(17)30018.
    PubMed     Text format     Abstract available


    Int J Cancer

  24. SHEN J, Li Z, Song Z, Chen J, et al
    Genome-wide two-locus interaction analysis identifies multiple epistatic SNP pairs that confer risk of prostate cancer: A cross-population study.
    Int J Cancer. 2017 Jan 25. doi: 10.1002/ijc.30622.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  25. HOLCH P, Henry AM, Davidson S, Gilbert A, et al
    Acute and Late Adverse Events Associated With Radical Radiation Therapy Prostate Cancer Treatment: A Systematic Review of Clinician and Patient Toxicity Reporting in Randomized Controlled Trials.
    Int J Radiat Oncol Biol Phys. 2017;97:495-510.
    PubMed     Text format     Abstract available

  26. MIRHADI AJ, Zhang Q, Hanks GE, Lepor H, et al
    Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202.
    Int J Radiat Oncol Biol Phys. 2017;97:511-515.
    PubMed     Text format     Abstract available

  27. SHAVERDIAN N, Verruttipong D, Wang PC, Kishan AU, et al
    Exploring Value From the Patient's Perspective Between Modern Radiation Therapy Modalities for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2017;97:516-525.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst


  28. Stat Bite Prostate Cancer Incidence and Death Rates.
    J Natl Cancer Inst. 2017;109:6.
    PubMed     Text format    

  29. SCHMIDT C
    Reconsidering Prostate Cancer Screening.
    J Natl Cancer Inst. 2017;109:1-2.
    PubMed     Text format    


    J Urol

  30. KILPELAINEN TP, Pogodin-Hannolainen D, Kemppainen K, Talala K, et al
    Estimate of opportunistic prostate-specific antigen testing in the Finnish Randomized Study of Screening for Prostate Cancer.
    J Urol. 2017 Jan 16. pii: S0022-5347(17)30074-5. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available


    N Engl J Med

  31. MYGATT JG, Osborn DJ
    DNA-Repair Gene Mutations in Metastatic Prostate Cancer.
    N Engl J Med. 2016;375:1803-4.
    PubMed     Text format    


    Nat Rev Urol

  32. STONE L
    Prostate cancer: Hand in hand - Rb1 and Trp53 cooperate to suppress resistance.
    Nat Rev Urol. 2017 Jan 24. doi: 10.1038/nrurol.2017.
    PubMed     Text format    

  33. FENNER A
    Prostate cancer: Genomic drivers of BRCA2-mutant tumours.
    Nat Rev Urol. 2017 Jan 24. doi: 10.1038/nrurol.2017.
    PubMed     Text format    

  34. VECCIA A, Maines F, Kinspergher S, Galligioni E, et al
    Cardiovascular toxicities of systemic treatments of prostate cancer.
    Nat Rev Urol. 2017 Jan 24. doi: 10.1038/nrurol.2016.
    PubMed     Text format     Abstract available


    PLoS One

  35. YU S, Wang Y, Yuan H, Zhao H, et al
    Knockdown of Mediator Complex Subunit 19 Suppresses the Growth and Invasion of Prostate Cancer Cells.
    PLoS One. 2017;12:e0171134.
    PubMed     Text format     Abstract available


    Prog Urol

  36. DAUBISSE-MARLIAC L, Lamy S, Lunardi P, Tollon C, et al
    [Prostate cancer: Quality assessment of clinical management in the Midi-Pyrenean region in 2011].
    Prog Urol. 2017 Jan 20. pii: S1166-7087(16)30779.
    PubMed     Text format     Abstract available


    Prostate

  37. FITZGERALD LM, Naeem H, Makalic E, Schmidt DF, et al
    Genome-Wide Measures of Peripheral Blood Dna Methylation and Prostate Cancer Risk in a Prospective Nested Case-Control Study.
    Prostate. 2017 Jan 24. doi: 10.1002/pros.23289.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: